Publications

January 2006 (Revised May 2007)
Case

Endo Pharmaceuticals (A): From LBO to...?

By: Richard G. Hamermesh and Brian DeLacey

Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company. View Details

Keywords: Private Equity; Initial Public Offering; Leveraged Buyouts; Mergers and Acquisitions; Health Care and Treatment; Pharmaceutical Industry; United States

January 2002 (Revised July 2002)
Teaching Note

Vialog Corporation (TN)

By: Richard G. Hamermesh and Michele Lutz

January 2001 (Revised April 2001)
Case

Lawyers & Leases

By: Richard G. Hamermesh and Michele Lutz

Profiles Rajath Chaundry, an aspiring entrepreneur, as he attempts to secure office space for his growing team, select a lawyer, and continue to build his fledgling enterprise, eLearning.com. Designed to be used in an entrepreneurial management or small business course... View Details

Keywords: Entrepreneurship; Business or Company Management; Business Ventures; Corporate Entrepreneurship; Intellectual Property; Management Succession; Leasing; Negotiation; Education Industry; Legal Services Industry

December 1998 (Revised May 1999)
Case

Specialty Medical Chemicals

By: Richard G. Hamermesh and Lucinda Doran

A new general manager is supposed to rekindle growth. Seven months later, he questions the abilities of his direct reports. An organizational psychologist is brought in to assess his people. The general manager now has to decide who to keep and how to structure his... View Details

Keywords: Decisions; Employees; Leadership Development; Management Teams; Organizational Structure; Cognition and Thinking

Web

Kraft Accelerator

Hamermesh and Kathy Guisti, plus leaders in the field, including John Wilbanks of Sage Bionetworks, David Shaywitz of Takeda Ventures, Jeff Elton from Concerto Health AI, Wout Brusselaers, Founder & CEO of Deep6, View Details

February 1988
Case

Crown Cork & Seal Co., Inc. (Condensed)

By: Richard G. Hamermesh and Richard S. Rosenbloom

A condensed version of Crown Cork & Seal Co., Inc. The principal changes are the elimination of details about the early history of the company and condensation of the final section, Outlook for the Future. View Details

Keywords: Risk and Uncertainty; Industry Growth; Environmental Sustainability; Business Strategy; Trends; Manufacturing Industry

March 2015 (Revised June 2015)
Case

Medalogix

By: Richard G. Hamermesh and Matthew G. Preble

This case examines an exciting new approach to health care that will help care providers identify when hospice services are the appropriate type of care for patients. The company, Medalogix, already has a product on the market that uses a proprietary algorithm to... View Details

Keywords: Health Care; Health Care Entrepreneurship; Health Care Services; Implementing Strategy; Dissemination; Innovation; Market Selection; Health; Health Care and Treatment; Analytics and Data Science; Marketing Strategy; Innovation and Management; Innovation Strategy; Health Industry; United States

02 Jun 2010
First Look

First Look: June 2

Lead Times Authors:Santiago Kraiselburd, Richard Pibernik, and Ananth Raman Publication:Production and Operations Management (forthcoming) Abstract It is generally a well acknowledged fact that, ceteris paribus, reducing the lead times... View Details

Keywords: Martha Lagace

August 2013 (Revised October 2013)
Case

MedImmune Ventures

By: Richard G. Hamermesh and David Lane

Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details

Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London

May 2012
Supplement

Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)

By: Richard G. Hamermesh and Alisa Zalosh

November 2012
Supplement

Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)

By: Richard G. Hamermesh and Alisa Zalosh

November 2012
Teaching Note

Sugar Bowl (Brief Case) (TN)

By: Richard G. Hamermesh and Alisa Zalosh

December 2012
Teaching Note

Gene Patents (A) (TN)

By: Richard G. Hamermesh and Matthew Preble

This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details

Keywords: Biotech; Human Genome; Patents; Genetics; Biotechnology Industry; United States

July 2012 (Revised May 2024)
Supplement

Lyric Dinner Theater (B)

By: Richard G. Hamermesh and Jim Sharpe

Supplements the (A) Case. Deborah Denenberg reflects on the results and actions taken during the 12 months following her first 6 months on the job. View Details

Keywords: Entrepreneurs; Entrepreneurial Management; Crisis; Turn; Family Business; Financial Crisis; Boards Of Directors; Operations Management; Strategy Implementation; Career Planning; Entrepreneurship; Entertainment and Recreation Industry; United States

October 2010 (Revised June 2015)
Teaching Note

MINTing Innovation at NewYork-Presbyterian (A) and (B)

By: Richard G. Hamermesh and David Kiron

Teaching Note for 810004 and 815113. View Details

Keywords: Commercialization; Technological Innovation; Health Industry

April 2009
Teaching Note

Amylin Pharmaceuticals: Diabetes and Beyond (TN)

By: Richard G. Hamermesh and Rachel Gordon

Teaching Note for [809011]. View Details

Keywords: Negotiation Deal; Product Development; Success; Commercialization; Governing Rules, Regulations, and Reforms; Resource Allocation; Pharmaceutical Industry

September 2007 (Revised October 2010)
Case

DermaCare: Zapping Zits Directly

By: Richard G. Hamermesh and Lauren Barley

DermaCare has developed an innovative new product for the treatment of acne that they hope to sell to consumers via direct-response television. The unconventional nature of the product and its distribution has led the company to seek angel financing. The Silicon Valley... View Details

Keywords: Decision Choices and Conditions; Venture Capital; Investment; Innovation and Invention; Product; California

May 2007
Teaching Note

DentalCorp (TN)

By: Richard G. Hamermesh and Erin Seefeld

Keywords: Health; Health Industry

October 2006 (Revised August 2007)
Case

Calloway Laboratory: Pee for Profit

By: Richard G. Hamermesh and David Kiron

Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details

Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry